{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Carine Steiner"}, {"accession": "MS:1000589", "name": "contact email", "value": "carine.steiner@roche.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "F. Hoffmann-La Roche"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Ducret Axel"}, {"accession": "MS:1000589", "name": "contact email", "value": "axel.ducret@roche.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Translational Technologies and Bioinformatics, Pharmaceutical Sciences, Roche Pharma Research & Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070 Basel, Switzerland"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/2012_05_18_PAA_OT_14_CAS_BT474.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/2012_05_30_FRF_OT_43_CAS_BT474.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/2012_05_30_FRF_OT_49_CAS_SKBR3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/2012_06_21_CAP_OT_143_Cas_BT474_Eluat_1_8.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/B2_3.RAW"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/FDR5_2012_05_18_BT474_1MC.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/FDR5_2012_05_30_BT474_1MC.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/FDR5_2012_05_30_BT474_1MC_CysCAMvar.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/FDR5_2012_05_30_SK-BR3_1MC.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/FDR5_2012_05_30_SK-BR3_1MC_CysCAMvar.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/FDR5_2012_06_21_1_8_BT474_Eluat_1MC_CysCAMvar.xlsx"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281/summary_peptides_in_which_experiments_Sabine_list_Axel.xlsx"}], "description": "The ability to accurately quantify proteins in formalin-fixed paraffin-embedded (FFPE) tissues using targeted mass spectrometry opens exciting perspectives for biomarker discovery. We have developed and evaluated a selected reaction monitoring (SRM) assay for the human receptor tyrosine-protein kinase erbB-2 (HER2) in FFPE breast tumors. Peptide candidates were identified using an untargeted mass spectrometry approach in relevant cell lines. A selected reaction monitoring (SRM) assay was developed for the six best candidate peptides and evaluated for linearity, precision and lower limit of quantification. The six HER2 peptides of interest were then quantified by SRM in a cohort of 40 archival formalin-fixed paraffin-embedded tumor tissues from women with invasive breast carcinomas, showing different levels of HER2 gene amplification. Finally, the agreement was tested between data generated by SRM and data generated using standard clinical pathology methods, namely immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). The high agreement observed indicates that SRM is a suitable method to quantify peptides from FFPE material, and therefore represents a powerful approach for biomarker discovery studies.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/07/PXD002281"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD002281"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD002281"}], "instruments": [{"accession": "MS:1001742", "name": "LTQ Orbitrap Velos"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "human receptor tyrosine-protein kinase erbB-2 (HER2), formalin-fixed parrafin-embedded tissues (FFPE), breast cancer, human, LTQ Orbitrap Velos"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "26149442"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Steiner C, Tille JC, Lamerz J, Kux van Geijtenbeek S, McKee TA, Venturi M, Rubbia-Brandt L, Hochstrasser D, Cutler P, Lescuyer P, Ducret A. Quantification Of HER2 By Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissues. Mol Cell Proteomics. 2015 Jul 6. pii: mcp.O115.049049"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Identification of HER2 peptides for quantification in formalin-fixed paraffin-embedded breast cancer tissues"}